Pacira BioSciences: Not Done Yet Despite Devastating Share Price Losses
If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.Pacira BioSciences, Inc. (NASDAQ: PCRX ) stock currently trades at a value of 115 per share, and in March 2022, >$75 per share. Since th ...